Mid-market investment bank Lincoln International has strengthened its healthcare investment banking practice with the addition of Barry Freeman as Managing Director. “I am delighted to be joining the successful and growing Lincoln organization. In my previous role in healthcare private equity, I saw firsthand the array of healthcare investment banking firms in the market. I believe Lincoln stands alone among the field marrying unparalleled understanding across the breadth of the healthcare landscape with the depth of global access and relationships,” said Mr. Freeman.
The addition of Barry Freeman seamlessly complements and deepens our current healthcare industry expertise and fits with our integrated and international culture,” said Lincoln International’s CEO North America, Robert Barr. “Barry joins Lincoln’s Global Healthcare Group at an exciting time, and the most active start to a year in the Group’s history. We are certain that Barry will be a strong asset to our team and the clients that we serve and contribute significantly to the growth of our healthcare advisory practice.”
Since the launch of its healthcare group in 2010, Lincoln International’s global healthcare team has grown to over 25 professionals worldwide. Lincoln International’s Global Healthcare Group, one of the largest in the middle-market, focuses on serving companies in the following sectors: provider services, medical devices and products, diagnostics and research tools, contract services and process outsourcing.
Mr. Freeman, a 20-year veteran of investment banking and principal investing, brings broad healthcare services experience, including many cross-border transactions to his role at Lincoln International. He has served clients and managed investments across managed care, outsourced healthcare services, home healthcare, alternate site providers, post-acute care, medical equipment, infusion/pharmacy, health and wellness and healthcare technology. Mr. Freeman’s healthcare clients have included privately-held entities, private equity-owned enterprises, and publicly traded corporations. He was most recently with Summer Street Capital, where he served as the head of its healthcare group, and prior to that position he spent 14 years with Lazard Middle Market, and its predecessor Goldsmith Agio Helms, where he led both its healthcare services group and its Chicago office.
Mr. Freeman joins a seasoned and growing team of Managing Directors in Lincoln International’s Chicago office, including Michael Weber and Nick Konstantinou, who joined Lincoln International’s healthcare practice in late 2012 from BB&T Capital Markets, where they co-led the healthcare practice. Lincoln International initially launched its healthcare practice in January 2010, with Managing Director Shahab Fatheazam, previously head of the healthcare practice at GCA Savvian, who leads the group.
Lincoln International also recently expanded its healthcare practice in Europe with the addition of Attila Kravecz, previously in the Healthcare M&A groups at HSBC and Dresdner Kleinwort, in its Frankfurt office to cover the healthcare sector in Germany, Austria, Switzerland and the Benelux region. Mr. Kravecz has 15 years of experience in healthcare M&A and is a strong addition to the global healthcare team.
“Lincoln International’s focus on the healthcare sector in the last three years reflects its commitment to serving its broad range of clients in growth sectors in the world’s key economies,” said Jim Lawson, Chairman of Lincoln International. Since 2010, Lincoln International’s healthcare team has successfully completed transactions such as the sale of Plastiques Gosselin, a portfolio company of Qualium, to Corning; the Sekisui Medical acquisition of Genzyme Diagnostics; the sale of Advanced Physical Therapy, a portfolio company of Cardinal Equity Partners, to ATI Physical Therapy, a portfolio company of GTCR; the sale of Reichert Technologies, a portfolio company of Beecken Petty O’Keefe & Company, to Ametek; the sale of Völker to Hill-Rom; the sale of Coeur, a portfolio company of The Riverside Company, to ITW; and the sale of Defibtech to Nihon Kohden. “With an increase in M&A activity in the healthcare product and service sectors,” said Mr. Lawson, “the timely addition of Mr. Freeman further strengthens the global healthcare team’s capabilities and market-leading industry expertise.”
Lincoln International specializes in merger and acquisition advisory services, debt advisory services, private capital raising and restructuring advice on mid-market transactions. Lincoln International also provides fairness opinions, valuations and pension advisory services on a wide range of transaction sizes. With thirteen offices in the Americas, Asia and Europe, Lincoln International has strong local knowledge and contacts in key global economies. The firm provides clients with senior-level attention, in-depth industry expertise and integrated resources. Lincoln International is based in Chicago (www.lincolninternational.com).
© 2013 PEPD • Private Equity’s Leading News Magazine • 3-18-13
